1688-0390
1688-0390
S1688-03902021000301201
10.29193/rmu.37.3.1
Uruguay
Uruguay
Uruguay
Uruguay
Uruguay
Uruguay
Uruguay
Uruguay
00
09
2021
00
09
2021
37
3
[
2000
16
Suppl 1
Suppl 1
S2-5
]
[
2013
2013
837620
]
[
2018
15
1
1
43-52
]
[
2016
24
112-26
]
[
2007
3
1
1
65-76
]
[
2015
8
1-8
]
[
1988
266
319-29
]
[
1990
170
1
1
56-60
]
[
2012
9
1
1
59-67
]
[
Autologel Diabetic Foot Ulcer Study Group
2006
52
6
6
68-74
]
[
2008
84
2
2
415-21
]
[
2012
43
5
5
762-5
]
[
2016
5
5
CD006899
]
[
2019
8
7
7
298-308
]
[
2016
137
1498-506
]
[
2015
23
5
5
638-43
]
[
2017
56
2
2
160-4
]
[
2020
9
6
6
22
]
[
2015
23
3
3
379-85
]
[
2001
24
1
1
84-8
]
[
2016
15
1
1
45-51
]
[
2003
14
500-8
]
[
British Committee for Standards in Haematology.Blood Transfusion Task Force
2003
122
10-23
]
[
2010
51
2
2
476-86
]
[
Apligraf Diabetic Foot Ulcer Study
2001
24
2
2
290-5
]
[
2009
6
3
3
196-208
]
[
2007
33
3
3
155-62
]
[
2010
4
5
5
1121-6
]
[
2013
2013
837620
]
[
2015
23
4
4
495-505
]
[
2008
22
4
4
468-71
]
[
2010
56
6
6
36-44
]
[
2010
23
6
6
262-72
]
[
2012
58
4
4
36-49
]
[
1998
21
822-7
]
[
1996
19
350-4
]
[
2013
2013
269527
]
[
2009
2
2
2
67-72
]
[
2012
29
32-6
]
[
2010
160
169-77
]
[
2008
21
12
12
568-75
]
[
2001
27
4
4
347-51
]
[
International Diabetes Federation
2017
]
[
2014
28
5
5
632-8
]
[
1996
4
2
2
230-3
]
[
2001
24
3
3
483-8
]